Introduction
African trypanosomes are of considerable medical and economic importance because they cause a debilitating disease in humans (sleeping sickness) and livestock (nagana) throughout a large portion of sub-Saharan Africa (1) . These parasites have a digenetic life cycle, with two main stages: the bloodstream form (BF) that lives in the bloodstream of its mammalian host, and the procyclic form (PF) that lives in the insect vector (tsetse fly). Purines are essential for the growth, multiplication and survival of these organisms because the parasites are incapable of synthesizing the purine ring de novo (2, 3) . Furthermore, nucleoside/nucleobase transporters are of considerable pharmacological importance, as both purine analogs and non-purine analog drugs are taken up by some of these permeases, and loss of permease function can lead to drug resistance (4,5).
Two different nucleoside transport systems have been characterized in intact T. brucei cells. The P1 type system mediates the uptake of purine nucleosides (adenosine, inosine and guanosine), and is detected in both BF and PF life cycle stage, and the P2 type system mediates the uptake of adenosine and adenine, as well as several anti-trypanosomal drugs, and is detected only in the BF (6, 7) parasites. In addition, four nucleobase transport activities have also been identified. H1, H2 and H3 mediate the transport of hypoxanthine, guanine and adenine (8, 9) . H1 activity is found in PF, and H2 and H3 activities are found in BF. In addition, the U1 activity mediates the transport of uracil in PFs (10). However, meticulous functional and biochemical characterization of these transporters at the molecular level is needed to understand the biological role of purine transporters in survival and adaptation of T. brucei to different environments during its life cycle and to provide information about drug delivery and drug resistance phenotypes associated with purine transporters (11) . Previously we cloned and characterized the Trypanosoma brucei nucleoside transporter 2, TbNT2, which is a P1 type transporter expressed only in the BFs (12) . In this manuscript we demonstrate that TbNT2 is a member of a multi-gene family. In the reference strain TREU 927 used for the T. brucei genome project (http://parsun1.path.cam.ac.uk/index.htm), this family encodes 6 similar but distinct transporters, denominated TbNT2/927 to TbNT7 (the designation TbNT2/927 is used to distinguish this gene from the closely related but nonetheless distinct TbNT2 gene that was derived originally from T. brucei strain EATRO 110 (12) ). All the family members are clustered together in chromosome number II and are separated by ~9 kb intergenic regions. Functional expression of TbNT2/927 through TbNT7 in Xenopus oocytes revealed that TbNT2/927, TbNT5, TbNT6 and TbNT7 transport purine nucleosides with similar affinities in the low micromolar range. Of note, TbNT5, and to a lesser extent TbNT6 and TbNT7, also show significant hypoxanthine transport activity. Moreover, ribonuclease protection assays indicate that the mRNAs from all 6 genes are expressed in BF parasites, but only TbNT2/927 and TbNT5 mRNAs are expressed at detectable levels in both BFs and PFs. Consequently, members of this NT family are differentially regulated during the parasite life cycle and mediate the uptake of purine nucleosides and in some cases also the nucleobase hypoxanthine. The presence of several P1 type transporters with similar but distinct biochemical properties and divergent regulation of expression suggests that the purine transport process in T. brucei is much more complex than was assumed on the basis of previous studies with whole parasites. brucei strain TREU 927 from frozen stocks were grown in Wistar rats, and blood was collected through exsanguination. BFs were separated from blood cells on a DE52 (Whatman) anion exchange column as described (15) . Nucleic acids were purified from trypanosomes following established procedures (16) , and Southern blots were performed using standard protocols (16) . 
Material and Methods

Chemicals
Cloning and Sequencing of TbNT Family Members−
Results
The TbNT2/927 Gene Family Encodes P1 Type Nucleoside Transporter Isoforms−
Biochemical characterization of purine nucleoside transport in intact T. brucei parasites indicated the presence of P1 type transport that mediates the uptake of adenosine and inosine in both PFs and BFs (6) . In previous studies (12), we have cloned a P1 type transporter gene from T. brucei strain EATRO 110, called TbNT2 that is a high affinity adenosine/inosine transporter whose RNA is detectable only in BFs. Genomic Southern blots hybridized with the TbNT2 ORF indicated the presence of a multi-gene family, raising the possibility that some of these TbNT2-like genes might encode other P1 type transporters.
To clone TbNT2-like genes we first BLAST searched the T. brucei genome database using the TbNT2 amino acid sequence as query and 6 ORFs were identified. All the 6 ORFs were contained in the same RPCI-93 BAC clone 36E18, which contains a genomic DNA insert from chromosome number II of T. brucei strain TREU 927 (www.tigr.org/tdb/mdb/tbdb/progress.html), and the predicted amino acid sequences showed high identity to TbNT2 (81% to 96% identity). The gene that predicted a protein with the highest identity (96%) to the original TbNT2 was designated T. brucei nucleoside transporter 2/927 (TbNT2/927). Moreover, TbNT2/927 is the first gene in the array of the locus according to the predicted transcription direction (Fig. 1 ). The other P1 type genes were designated TbNT3 through TbNT7. All genes were cloned using a PCR strategy and sequenced to determine the identity of each one by comparing the DNA and predicted amino acid sequences against those obtained from the T. brucei database. In addition, we identify 5 copies of an interspersed nonrelated gene within the TbNTs array, encoding a putative isopenicillium-N-synthase gene (INS in Fig. 1 ).
Gene multiplicity is a common feature in kinetoplastid protozoa (21) , and each gene often encodes the same protein (22) . However in some examples, gene families encode similar but not identical proteins (23, 24) . The 6 predicted TbNT proteins were very similar along the entire amino acid sequences (Fig. 2) , suggesting that they are nucleoside transporter isoforms.
Moreover, the predicted topology indicated 11 TMDs for all 6 proteins, similar to the human equilibrative nucleoside transporter 1, hENT1, whose topology was recently experimentally elucidated by Sundaram et. al (25) .The 11 TMDs shown in Fig. 2 are those predicted for TbNT2/927. The overall comparison showed 4 regions of major divergence between the 6 protein sequences. Those regions are limited to the extracellular loops between TMD1 -TMD2, TMD5 -TMD6, TMD7 -TMD8 and the large intracellular loop between TMD 6 -7.
Functional Expression of TbNT2/927 Through TbNT7 in Xenopus Oocytes− To identify
the substrate specificity of the TbNT2/927 family members we tested the ability of oocytes expressing TbNT2/927 through TbNT7 to mediate the uptake of purine nucleosides. Initial experiments indicated that TbNT2/927, TbNT5, TbNT6 and TbNT7 cRNA injected oocytes were able to transport adenosine, inosine and guanosine at significantly higher rates than the control water injected oocytes (Fig. 3A) . However, TbNT3 and TbNT4 cRNA injected oocytes did not mediate the uptake of any purine nucleosides compared to the control water injected oocytes (data not shown). To characterize the affinity of these transporters for adenosine and inosine, K m s were calculated from substrate saturation curves (Fig. 3B) , revealing that TbNT2/927, TbNT5, TbNT6 and TbNT7 were high affinity adenosine/inosine transporters ( To test for potential functional differences between the distinct proteins, we also examined the ability of TbNT2/927 through TbNT7 to mediate the transport of purine nucleobases. Interestingly TbNT5 cRNA injected oocytes were able to mediate the uptake of hypoxanthine at a significantly higher level than the control water injected oocytes (Fig. 4) .
Moreover, saturation curves for TbNT5 revealed a K m value of 49.4 ± 13.3 µM (mean ± S. D., n= 3) for hypoxanthine. In contrast TbNT6 and TbNT7 showed limited but still significant hypoxanthine transport activity, while TbNT2/927, TbNT3 and TbNT4 did not show any ability to transport this nucleobase. Additional experiments were conducted to test the transport of guanine and adenine but none of the 6 permeases transported these purines (data not shown). In summary, there are clear differences in substrate specificitiy between members of the TbNT2/927 family. TbNT2/927 is a purine nucleoside transporter, TbNT5, TbNT6, and TbNT7 transport hypoxanthine in addition to the purine nucleosides, and TbNT3 and TbNT4 have not exhibited any clear transport activity for the substrates tested here including adenosine, inosine, guanosine, xanthosine, adenine, hypoxanthine, guanine, xanthine, cytosine, uracil, thymine, cytidine, thymidine, uridine, S-adenosyl methionine, spermidine, putrescine and adenosine monophosphate (AMP).
In intact T. brucei parasites, transport of nucleosides (7) and nucleobases (8) has been shown to be dependent upon the transmembrane proton motive force, strongly suggesting that these permeases are active proton symporters. Indeed, uptake of adenosine by TbNT2/927, TbNT5, TbNT6 and TbNT7 cRNA injected oocytes was significantly inhibited by FCCP or DNP (data not shown), suggesting that the adenosine uptake by these permeases is coupled to proton translocation. whereas P1 activity could be detected in both BFs and PFs (6). These results, along with the observation of multiple fragments on genomic Southern blots that hybridized to a TbNT2 probe (12) , suggested that other P1 type transporters were likely to exist. In this study, we report the functional expression and characterization of the TbNT2/927 gene family, 4 members of which encode high affinity adenosine, inosine, guanosine transporters, placing them within the P1 type of nucleoside transporters previously defined at the biochemical level (6, 12) . However, TbNT5, TbNT6 and TbNT7 were also able to mediate the uptake of hypoxanthine, a nucleobase that plays a central role in the purine salvage pathway of these parasites (3). This result is consistent with previous observations that some other ENT family members, specifically TbAT1 (26), hENT2 (27) , and PfNT1 (28), are able to transport some nucleobases, most often with substantially higher K m s than for nucleosides.
It will be interesting to determine what specific molecular determinants confer hypoxanthine transport function upon TbNT5, TbNT6 and TbNT7. Examination of the multialignment (Fig. 2 ) reveals that there are 5 amino acids (V47, K48, K52, P55, and V78 in TbNT5)
that are conserved in these 3 permeases but that are different in TbNT2/927, TbNT3 and TbNT4.
The first 4 of these residues are located in the extracellular loop between predicted TMDs 1 and 2, and V78 is located within predicted TMD2. It is possible that some of these residues confer hypoxanthine transport capacity upon TbNT5, TbNT6, and TbNT7.
It is noteworthy that we have not been able to identify any substrates for TbNT3 or TbNT4 in the Xenopus oocytes expression system. One possibility is that TbNT3 and TbNT4 are not functional transporters. Alternatively, the 2 permeases may transport some substrate that we have not tested. Compounds that we have examined as potential substrates for TbNT3 and TbNT4 include purine nucleosides and nucleobases, pyrimidine nucleosides and nucleobases, Sadenosyl methionine, polyamines, and AMP but none of these solutes are substrates. We have also considered the possibility that TbNT3 and TbNT4 could form functional hetero-oligomers.
However, coinjection of TbNT3 and TbNT4 cRNAs into oocytes did not elicit any transport function for any of the compounds listed above. Still another possible explanation for the failure of these proteins to mediate purine transport is that they require for function other subunits that are not present in the oocytes. The requirement for multiple subunits has been observed for several amino acid transporters (29) .
There is ample precedent for the existence of multiple isoforms of various transporters in both unicellular and multicellular eukaryotes (30,31). In multicellular organisms, distinct isoforms may be expressed in different tissues where they subserve the physiological needs of each cell type (32). The TbNT2/927 family encompasses 6 permeases whose sequences are distinct but closely related. It is possible that each permease has unique properties that collectively promote the viability of the parasite in its natural environment. Thus, examination of substrate specificity for each permease has revealed differences that could in part explain the distinct roles of different family members. Furthermore all 6 mRNAs are expressed in BF TbNT2/927  TbNT3  TbNT4  TbNT5  TbNT6  TbNT7   99  99  98  100  99  99 TbNT2/927  TbNT3  TbNT4  TbNT5  TbNT6  TbNT7   198  199  198  199  198  198 TbNT2/927  TbNT3  TbNT4  TbNT5  TbNT6  TbNT7   246  248  243  248 TbNT2/927  TbNT3  TbNT4  TbNT5  TbNT6  TbNT7   296  298  293  298  298  297 TbNT2/927  TbNT3  TbNT4  TbNT5  TbNT6  TbNT7   346  348  343  348  346  347 TbNT2/927  TbNT3  TbNT4  TbNT5  TbNT6  TbNT7   396  398  393  398  396  397 TbNT2/927  TbNT3  TbNT4  TbNT5  TbNT6  TbNT7   446  448  443  448  446  447 TbNT2/927  TbNT3  TbNT4  TbNT5  TbNT6  TbNT7   462  464  461  463  462  467 TMD1   TMD2   TMD3  TMD4   TMD5   TMD6   TMD7   TMD8  TMD9   TMD10 
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